Takeda Pharmaceutical Company Limited (TAK) Stock Analysis | Financial Data & Charts

Investment Radar

Seven-Dimensional Value Assessment Based on 2025 Q4 Financials

加载雷达图...

加载图表中...

📊 Valuation

Key valuation metrics

EV/EBITDA (TTM)

i

Enterprise Value, EBITDA and Ratio

EV/EBIT (TTM)

i

Enterprise Value, EBIT and Ratio

EV/Sales (TTM)

i

Enterprise Value, Revenue and Ratio

P/E Ratio (TTM)

i

Market Cap, Net Income and Ratio

P/B Ratio (Quarterly)

i

Market Cap, Book Value and Ratio

FCF Yield (TTM)

i

FCF, Enterprise Value and Yield

PR Profit Ratio (PPM)

i

PE Ratio, ROE and Profit Ratio (PR = PE / ROE)

📈 Growth

Revenue, earnings, and per-share growth metrics

Revenue (Quarterly)

i

Quarterly Revenue

Revenue/Share (Quarterly)

i

Revenue Per Share

Net Income (Quarterly)

i

Quarterly Net Income

EPS (Quarterly)

i

Earnings Per Share

Gross Profit/Share (Quarterly)

i

Gross Profit Per Share

OCF/Share (Quarterly)

i

Operating Cash Flow Per Share

FCF/Share (Quarterly)

i

Free Cash Flow Per Share

Operating Leverage (YoY)

i

Change in Operating Income / Change in Revenue

💰 Profitability

Profit margins and return on equity

Gross Margin (TTM)

i

Revenue, Gross Profit and Gross Margin

Operating Margin (TTM)

i

Revenue, Operating Income and Operating Margin

Net Profit Margin (TTM)

i

Revenue, Net Income and Net Profit Margin

ROE (TTM)

i

Equity, Net Income and Return on Equity

ROA (TTM)

i

Assets, Net Income and Return on Assets

ROTCE - Return on Tangible Common Equity (TTM)

i

Net Income, Tangible Common Equity and ROTCE

OCF Margin (TTM)

i

Revenue, Operating Cash Flow and OCF Margin

FCF Margin (TTM)

i

Revenue, Free Cash Flow and FCF Margin

💵 Cash Quality

Cash flow quality and conversion metrics

OCF/NI Ratio (TTM)

i

Operating Cash Flow, Net Income and Ratio

FCF/NI Ratio (TTM)

i

Free Cash Flow, Net Income and Ratio

OCF/Capex (TTM)

i

Operating Cash Flow, Capex and Coverage Ratio

OCF/SBC (TTM)

i

Operating Cash Flow, SBC and Coverage Ratio

🛡️ Leverage & Liquidity

Debt, liquidity, and financial health

Debt/Equity (quarterly)

i

Total Debt, Total Equity and Debt/Equity Ratio

EBITDA/Net Debt (TTM)

i

EBITDA, Net Debt and Coverage Ratio

Interest Coverage (TTM)

i

EBIT, Interest Expense and Coverage Ratio

Current Ratio (quarterly)

i

Current Assets, Current Liabilities and Current Ratio

Quick Ratio (quarterly)

i

Quick Assets, Current Liabilities and Quick Ratio

Altman Z-Score

i

Financial Distress Prediction Model

⚙️ Ops & Cap Efficiency

Asset utilization, working capital, ROIC, and capital efficiency

ROIC (TTM)

i

NOPAT, Invested Capital and Return on Invested Capital

ROCE - Return on Capital Employed (TTM)

i

EBIT, Capital Employed and Return on Capital Employed

Asset Turnover (TTM)

i

Revenue, Total Assets and Turnover Ratio

CapEx/Depreciation - Investment Intensity (TTM)

i

CapEx, Depreciation and Ratio (>1=Expansion, <1=Contraction)

R&D/Gross Profit - R&D Intensity (TTM)

i

R&D Expenses, Gross Profit and Ratio

SG&A/Revenue - SG&A Efficiency (TTM)

i

SG&A Expenses, Revenue and Ratio

Cash Conversion Cycle (TTM)

i

DSO + DIO - DPO (in days)

DSO - Days Sales Outstanding (TTM)

i

Average Receivables and Days Sales Outstanding

DIO - Days Inventory Outstanding (TTM)

i

Average Inventory and Days Inventory Outstanding

DPO - Days Payables Outstanding (TTM)

i

Average Payables and Days Payables Outstanding

Goodwill/Assets (Quarterly)

i

Goodwill as % of Total Assets

🎁 Shareholder Returns

Dividends, share buybacks, dilution, and insider trading activity

Dividend Yield (TTM)

i

Dividend Per Share, Share Price and Dividend Yield

Buyback Yield (TTM)

i

Net Buyback and Buyback Yield

Buyback Yield (3 Years)

i

Net Buyback 3Y and Buyback Yield 3Y

Dilution Rate (1 Year)

i

Current Shares, 1Y Ago Shares and Dilution Rate

Dilution Rate (3 Years)

i

Current Shares, 3Y Ago Shares and Dilution Rate

SBC Offset Rate (TTM)

i

Buyback / Stock-Based Comp and SBC Ratio

Insider Activity Rate (TTM)

i

Insider Net Buying and Activity Rate

Profit Waterfall Analysis

加载图表中...

P

Profitability Margins

Gross Profit Margini

54.43%

Gross Profit = $4.38B

Revenue = $8.05B

Operating Profit Margini

16.00%

Operating Income = $1.29B

Revenue = $8.05B

EBITDA Margini

37.60%

EBITDA = $3.03B

Revenue = $8.05B

EBIT Margini

21.61%

EBIT = $0.90B

Revenue = $8.05B

Net Profit Margini

8.70%

Net Income = $0.70B

Revenue = $8.05B

Pretax Profit Margini

11.23%

EBT = $0.90B

Revenue = $8.05B

E

Operating Efficiency

Interest Coveragei

1.97x

EBIT (TTM) = $3.51B

Interest Expense (TTM) = $1.78B

1.7x

1.4x

2.4x

2.1x

2.0x

SG&A / Revenuei

23.73%

SG&A = $1.91B

Revenue = $8.05B

R&D / Revenuei

14.70%

R&D = $1.18B

Revenue = $8.05B

R

Return Metrics (TTM)

⚡ Ratios calculated in JPY to eliminate exchange rate impact

ROAi

1.05%

Net Income = $1.04B

Avg Total Assets = $98.80B

⚡ ROA Ratio = 1.05% (calculated in JPY to eliminate FX impact)

ROEi

2.13%

Net Income = $1.04B

Avg Equity = $48.77B

⚡ ROE Ratio = 2.13% (calculated in JPY to eliminate FX impact)

ROICi

2.41%

NOPAT (TTM) = $1.85B

Avg Invested Capital = $76.72B

(NOPAT = Operating Income × (1 - Effective Tax Rate))

(Avg IC = (Current IC + Year-Ago IC) / 2)

⚡ ROIC Ratio = 2.41% (calculated in JPY to eliminate FX impact)

Revenue Growthi

6.04%

Current Revenue = $1213.21B

Previous Revenue = $1144.11B

⚡ Revenue Growth = 6.04% (calculated in JPY to eliminate FX impact)

+12.8%

+3.0%

+0.2%

-8.4%

+6.0%

Operating Cash Flow/Sharei

$368.61

Operating CF = $1181.37B

Diluted Shares = 3.20B

$266.85

$345.92

$330.76

$347.03

$368.61

Comprehensive Analysis

⚡ YoY Growth & Margin按JPY计算，去除汇率影响

Income Statement Items	YoY Growth	Current Quarter Value	Trend
Revenue	+3.2%	$1213.21B	↑
Gross Profit	-15.5%	$660.35B, 54.43%	↓
Operating Income	+5.3%	$194.06B, 16.00%	↑
EBITDA	+20.0%	$456.22B, 37.60%	↑
EBT	+14.2%	$136.28B, 11.23%	↑
Net Income	+14.6%	$105.51B, 8.70%	↑
Diluted EPS	+15.1%	32.92	↑

加载图表中...

L

Liquidity Metrics

Current Ratioi

1.19

Normal

Total Current Assets = $20.53B

Total Current Liabilities = $17.20B

Quick Ratioi

0.65

Attention

Quick Assets = $11.26B

Total Current Liabilities = $17.20B

Cash Ratioi

0.25

Normal

Cash & Equivalents = $4.32B

Total Current Liabilities = $17.20B

Cash Ratio = (Cash + Short-term Investments) / Current Liabilities

L

Leverage Metrics

Debt to Equityi

0.64

Normal

Total Debt = $31.98B

Total Equity = $50.36B

Liabilities to Assetsi

50.4%

Normal

Total Liabilities = $51.16B

Total Assets = $101.52B

Equity Multiplieri

2.02

Normal

Total Assets = $101.52B

Total Equity = $50.36B

E

Efficiency Metrics

Asset Turnoveri

0.30

Attention

Revenue (TTM) = $30.12B

Avg Total Assets = $98.80B

Inventory Turnoveri

1.29

Attention

COGS (TTM) = $11.57B

Avg Inventory = $8.94B

Receivables Turnoveri

6.20

Normal

Revenue (TTM) = $30.12B

Avg Receivables = $4.85B

S

Solvency Metrics

Interest Coveragei

1.97

Attention

EBIT (TTM) = $3.51B

Interest Expense (TTM) = $1.78B

Net Debt to EBITDAiNet Debt/EBITDA

3.25

Attention

Net Debt = $27.66B

EBITDA (TTM) = $8.52B

Debt Service Coveragei

1.82

Normal

Operating CF (TTM) = $7.85B

Debt Service = $4.31B

V

Value Metrics

Goodwill %iGoodwill/Assets

37.3%

Attention

Goodwill = $37.91B

Total Assets = $101.52B

Working Capital Ratioi

0.03

Attention

Working Capital = $3.34B

Total Assets = $101.52B

加载图表中...

Cash Flow Waterfall Chart

加载图表中...

Inflow

Outflow

Subtotal

Start/End

C

Cash Flow Metrics

Operating Cash Flow TTMi

$7.35B

Free Cash Flow TTMi

$5.74B

FCF = OCF - CapEx

OCF (TTM) = $7.35B

CapEx (TTM) = $-1.47B

FCF Yieldi

1787.98%

Healthy

FCF (TTM) = $5.74B

Market Cap = $43.44B

OCF/Sales Ratioi

26.15%

Healthy

OCF (TTM) = $7.35B

Revenue (TTM) = $29.97B

⚡ OCF/Sales Ratio = 26.15% (Ratios calculated in JPY to eliminate exchange rate impact)

Q

Quality & Coverage Metrics

Income Qualityi

7.86x

Healthy

OCF (TTM) = $7.35B

Net Income (TTM) = $0.96B

⚡ Income Quality = 7.86x (Ratios calculated in JPY to eliminate exchange rate impact)

Cash Flow/Debti

0.24x

Normal

OCF (TTM) = $7.35B

Total Debt = $31.27B

⚡ Cash Flow/Debt = 0.24x (Ratios calculated in JPY to eliminate exchange rate impact)

Short Term Coveragei

0.45x

Normal

OCF (TTM) = $7.35B

Current Liabilities = $15.05B

⚡ Short Term Coverage = 0.45x (Ratios calculated in JPY to eliminate exchange rate impact)

Capex Coveragei

5.59x

Healthy

OCF (TTM) = $7.35B

CapEx (TTM) = $1.47B

⚡ Capex Coverage = 5.59x (Ratios calculated in JPY to eliminate exchange rate impact)

E

Efficiency Metrics

⚡ Ratios calculated in JPY to eliminate exchange rate impact

FCF/OCF Ratioi

82.10%

Healthy

FCF (TTM) = $5.74B

OCF (TTM) = $7.35B

Capex/Revenuei

4.68%

Healthy

CapEx (TTM) = $1.47B

Revenue (TTM) = $29.97B

Net Debt/EBITDAi

3.58

Attention

Net Debt = $28.84B

EBITDA (TTM) = $8.05B

G

Growth Metrics

OCF Growthi

40.68%

Healthy

Current OCF (TTM) = $7.35B

Previous OCF = $5.23B

Owner Earningsi

$4.51B

Healthy

Net Income (TTM) = $0.96B

+ D&A (TTM) = $5.02B

- CapEx (TTM) = $-1.47B

加载图表中...

Loading...

Takeda Pharmaceutical Company Limited

Investment Radar

🔍 Business Model Analysis (DuPont Model)

Leading Indicators

Financial Metrics

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)

EPS (Quarterly)

Gross Profit/Share (Quarterly)

OCF/Share (Quarterly)

FCF/Share (Quarterly)

Operating Leverage (YoY)

💰 Profitability

Gross Margin (TTM)

Operating Margin (TTM)

Net Profit Margin (TTM)

ROE (TTM)

ROA (TTM)

ROTCE - Return on Tangible Common Equity (TTM)

OCF Margin (TTM)

FCF Margin (TTM)

💵 Cash Quality

OCF/NI Ratio (TTM)

FCF/NI Ratio (TTM)

OCF/Capex (TTM)

OCF/SBC (TTM)

🛡️ Leverage & Liquidity

Debt/Equity (quarterly)

EBITDA/Net Debt (TTM)

Interest Coverage (TTM)

Current Ratio (quarterly)

Quick Ratio (quarterly)

Altman Z-Score

⚙️ Ops & Cap Efficiency

ROIC (TTM)

ROCE - Return on Capital Employed (TTM)

Asset Turnover (TTM)

CapEx/Depreciation - Investment Intensity (TTM)

R&D/Gross Profit - R&D Intensity (TTM)

SG&A/Revenue - SG&A Efficiency (TTM)

Cash Conversion Cycle (TTM)

DSO - Days Sales Outstanding (TTM)

DIO - Days Inventory Outstanding (TTM)

DPO - Days Payables Outstanding (TTM)

Goodwill/Assets (Quarterly)

🎁 Shareholder Returns

Dividend Yield (TTM)

Buyback Yield (TTM)

Buyback Yield (3 Years)

Dilution Rate (1 Year)

Dilution Rate (3 Years)

SBC Offset Rate (TTM)

Insider Activity Rate (TTM)

Income Statement Analysis

Profit Waterfall Analysis

Balance Sheet Analysis

Cash Flow Statement Analysis

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)